NCT01054170 Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE2
NCT01052428 Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease) Status COMPLETED Phase PHASE2/PHASE3
NCT01051505 A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01049360 Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo Status COMPLETED Phase PHASE2
NCT01048333 Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® Status COMPLETED Phase PHASE2
NCT01047553 Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE3
NCT01047176 Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins Status COMPLETED Phase N/A
NCT01046630 Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects Status COMPLETED Phase PHASE1
NCT01046357 A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687 Status COMPLETED Phase PHASE1
NCT01045161 Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38) Status COMPLETED Phase PHASE3
NCT01044459 Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35) Status COMPLETED Phase PHASE3
NCT01044342 A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition Status COMPLETED Phase PHASE1
NCT01043185 A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience Status COMPLETED Phase PHASE2
NCT01042977 Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT01039701 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01039402 Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France Status COMPLETED Phase N/A
NCT01037725 Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers Status COMPLETED Phase PHASE1